- Home
- PLRX vs CTO Comparison
PLRX vs CTO Comparison
Compare PLRX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- CTO
- Stock Information
- Founded
- PLRX 2015
- CTO 1902
- Country
- PLRX United States
- CTO United States
- Employees
- PLRX N/A
- CTO N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- CTO Real Estate Investment Trusts
- Sector
- PLRX Health Care
- CTO Real Estate
- Exchange
- PLRX Nasdaq
- CTO Nasdaq
- Market Cap
- PLRX 641.5M
- CTO 578.8M
- IPO Year
- PLRX 2020
- CTO N/A
- Fundamental
- Price
- PLRX $11.77
- CTO $19.45
- Analyst Decision
- PLRX Strong Buy
- CTO Strong Buy
- Analyst Count
- PLRX 7
- CTO 4
- Target Price
- PLRX $40.50
- CTO $21.50
- AVG Volume (30 Days)
- PLRX 544.4K
- CTO 452.3K
- Earning Date
- PLRX 02-26-2025
- CTO 02-20-2025
- Dividend Yield
- PLRX N/A
- CTO 7.83%
- EPS Growth
- PLRX N/A
- CTO N/A
- EPS
- PLRX N/A
- CTO 0.61
- Revenue
- PLRX N/A
- CTO $118,662,000.00
- Revenue This Year
- PLRX N/A
- CTO N/A
- Revenue Next Year
- PLRX N/A
- CTO $13.12
- P/E Ratio
- PLRX N/A
- CTO $32.11
- Revenue Growth
- PLRX N/A
- CTO 16.61
- 52 Week Low
- PLRX $10.22
- CTO $16.16
- 52 Week High
- PLRX $18.92
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- PLRX 34.86
- CTO 46.23
- Support Level
- PLRX $12.40
- CTO $19.25
- Resistance Level
- PLRX $13.71
- CTO $19.74
- Average True Range (ATR)
- PLRX 0.76
- CTO 0.41
- MACD
- PLRX -0.17
- CTO -0.03
- Stochastic Oscillator
- PLRX 18.66
- CTO 54.90
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.